| Scalable and accurate deep learning with electronic health records A Rajkomar, E Oren, K Chen, AM Dai, N Hajaj, M Hardt, PJ Liu, X Liu, ... NPJ digital medicine 1 (1), 18, 2018 | 3315 | 2018 |
| 1,135 genomes reveal the global pattern of polymorphism in Arabidopsis thaliana C Alonso-Blanco, J Andrade, C Becker, F Bemm, J Bergelson, ... Cell 166 (2), 481-491, 2016 | 1429 | 2016 |
| Advances in risk classification and treatment strategies for neuroblastoma NR Pinto, MA Applebaum, SL Volchenboum, KK Matthay, WB London, ... Journal of clinical oncology 33 (27), 3008-3017, 2015 | 1005 | 2015 |
| Epigenomic diversity in a global collection of Arabidopsis thaliana accessions T Kawakatsu, SC Huang, F Jupe, E Sasaki, RJ Schmitz, MA Urich, ... Cell 166 (2), 492-505, 2016 | 773 | 2016 |
| Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube MA Eckert, S Pan, KM Hernandez, RM Loth, J Andrade, SL Volchenboum, ... Cancer discovery 6 (12), 1342-1351, 2016 | 242 | 2016 |
| A phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent/refractory high‐risk neuroblastoma JG Villablanca, SL Volchenboum, H Cho, MH Kang, SL Cohn, ... Pediatric blood & cancer 63 (8), 1349-1356, 2016 | 113 | 2016 |
| Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: a study from the International Neuroblastoma Risk Group database DA Morgenstern, WB London, D Stephens, SL Volchenboum, T Simon, ... European Journal of Cancer 65, 1-10, 2016 | 108 | 2016 |
| Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project MA Applebaum, Z Vaksman, SM Lee, EA Hungate, TO Henderson, ... European Journal of Cancer 72, 177-185, 2017 | 102 | 2017 |
| Gene expression profiling of E wing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the C hildren's O ncology G roup SL Volchenboum, J Andrade, L Huang, DA Barkauskas, M Krailo, ... The Journal of Pathology: Clinical Research 1 (2), 83-94, 2015 | 102 | 2015 |
| Pharmacogenomics‐based point‐of‐care clinical decision support significantly alters drug prescribing PH O'Donnell, N Wadhwa, K Danahey, BA Borden, SM Lee, JP Hall, ... Clinical Pharmacology & Therapeutics 102 (5), 859-869, 2017 | 101 | 2017 |
| Use of wearable, mobile, and sensor technology in cancer clinical trials SM Cox, A Lane, SL Volchenboum JCO clinical cancer informatics 2, 1-11, 2018 | 89 | 2018 |
| Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia AWA Mohsen, BD Anderson, SL Volchenboum, KP Battaile, K Tiffany, ... Biochemistry 37 (28), 10325-10335, 1998 | 89 | 1998 |
| Comprehensive Pediatric Hospital Medicine LB Zaoutis, VW Chang | 88 | 2007 |
| Age, diagnostic category, tumor grade, and mitosis-karyorrhexis index are independently prognostic in neuroblastoma: an INRG project E Sokol, AV Desai, MA Applebaum, D Valteau-Couanet, JR Park, ... Journal of Clinical Oncology 38 (17), 1906-1918, 2020 | 86 | 2020 |
| Tailoring therapy for children with neuroblastoma on the basis of risk group classification: past, present, and future WH Liang, SM Federico, WB London, A Naranjo, MS Irwin, ... JCO Clinical Cancer Informatics 4, 895-905, 2020 | 82 | 2020 |
| Second malignancies in patients with neuroblastoma: The effects of risk‐based therapy MA Applebaum, TO Henderson, SM Lee, N Pinto, SL Volchenboum, ... Pediatric blood & cancer 62 (1), 128-133, 2015 | 80 | 2015 |
| Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation Z Lu, Z Cheng, Y Zhao, SL Volchenboum PloS one 6 (12), e28228, 2011 | 72 | 2011 |
| CAPriCORN: Chicago area patient-centered outcomes research network AN Kho, DM Hynes, S Goel, AE Solomonides, R Price, B Hota, SA Sims, ... Journal of the American Medical Informatics Association 21 (4), 607-611, 2014 | 70 | 2014 |
| Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer AJ Church, LB Corson, PC Kao, A Imamovic-Tuco, D Reidy, D Doan, ... Nature medicine 28 (8), 1581-1589, 2022 | 67 | 2022 |
| Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group … S Hettmer, CM Linardic, A Kelsey, ER Rudzinski, C Vokuhl, J Selfe, ... European Journal of Cancer 172, 367-386, 2022 | 64 | 2022 |
